Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals

Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals

Abstract Surveillance of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic requires tests to monitor antibody formation and prevalence. We detected SARS‐CoV‐2 antibodies using red cells coated by Kode technology with short peptides derived from the SARS‐CoV‐2 spike protein (S...

Full description

Bibliographic Details
Main Authors: Christof Weinstock, Willy A. Flegel, Kshitij Srivastava, Sabine Kaiser, Hubert Schrezenmeier, Chrysanthi Tsamadou, Carolin Ludwig, Bernd Jahrsdörfer, Nicolai V. Bovin, Stephen M. Henry
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:eJHaem
Subjects:
antibody testing
C19‐kodecytes
COVID‐19
red cells
SARS‐CoV‐2
vaccination monitoring
Online Access:https://doi.org/10.1002/jha2.352

Internet

https://doi.org/10.1002/jha2.352

Similar Items